C-Further Selects MiNK’s iNKT Platform for First Pediatric Oncology Partnership

MiNK Therapeutics announces a new collaboration with C-Further to advance PRAME-targeted iNKT cell therapy for pediatric cancers, including up to $1.1 million in funding.